Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

Clinical trial NCT03748628 · COMPLETED

Trial details

NCT number: NCT03748628
Sponsor: Enanta Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2018-10-05
Primary completion: 2018-10-13
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.